medical device investing Spectral Expands its Renal Replacement Therapy Development Program to Include the Home Dialysis Market
Spectral Announces Publication of the post hoc analysis of EUPHRATES trial in Intensive Care Medicine
Skyharbour Intersects High-Grade Uranium in Significant 42 m Step Out Hole ML24-15 which Returned 4.74% U3O8 over 1.5 m within 6.4 m of 1.50% U3O8 at Moore Project
Finlay Minerals Announces Closing of Non-Brokered Private Placement of Flow-Through Shares and Non-Flow-Through Units